BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32152405)

  • 1. The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis.
    Díaz-Valdivia NI; Díaz J; Contreras P; Campos A; Rojas-Celis V; Burgos-Ravanal RA; Lobos-González L; Torres VA; Perez VI; Frei B; Leyton L; Quest AFG
    Oncogene; 2020 Apr; 39(18):3693-3709. PubMed ID: 32152405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.
    Lobos-González L; Aguilar L; Diaz J; Diaz N; Urra H; Torres VA; Silva V; Fitzpatrick C; Lladser A; Hoek KS; Leyton L; Quest AF
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):555-70. PubMed ID: 23470013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.
    Lobos-González L; Oróstica L; Díaz-Valdivia N; Rojas-Celis V; Campos A; Duran-Jara E; Farfán N; Leyton L; Quest AFG
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis.
    Ortiz R; Díaz J; Díaz N; Lobos-Gonzalez L; Cárdenas A; Contreras P; Díaz MI; Otte E; Cooper-White J; Torres V; Leyton L; Quest AF
    Oncotarget; 2016 Jun; 7(26):40571-40593. PubMed ID: 27259249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
    Ortiz R; Díaz J; Díaz-Valdivia N; Martínez S; Simón L; Contreras P; Lobos-González L; Guerrero S; Leyton L; Quest AFG
    Biochem Pharmacol; 2020 Jul; 177():113941. PubMed ID: 32240650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
    Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
    Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells.
    Castillo Bennett J; Silva P; Martinez S; Torres VA; Quest AFG
    Curr Mol Med; 2018; 18(4):199-206. PubMed ID: 30259813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis.
    Guerrero S; Díaz-García VM; Contreras-Orellana P; Lara P; Palma S; Guzman F; Lobos-Gonzalez L; Cárdenas A; Rojas-Silva X; Muñoz L; Leyton L; Kogan MJ; Quest AF
    Nanomedicine (Lond); 2018 Jun; 13(12):1447-1462. PubMed ID: 29972676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.
    Belle L; Ali N; Lonic A; Li X; Paltridge JL; Roslan S; Herrmann D; Conway JR; Gehling FK; Bert AG; Crocker LA; Tsykin A; Farshid G; Goodall GJ; Timpson P; Daly RJ; Khew-Goodall Y
    Sci Signal; 2015 Feb; 8(364):ra18. PubMed ID: 25690013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.
    Capozza F; Trimmer C; Castello-Cros R; Katiyar S; Whitaker-Menezes D; Follenzi A; Crosariol M; Llaverias G; Sotgia F; Pestell RG; Lisanti MP
    Cancer Res; 2012 May; 72(9):2262-74. PubMed ID: 22396494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.
    Po'uha ST; Le Grand M; Brandl MB; Gifford AJ; Goodall GJ; Khew-Goodall Y; Kavallaris M
    Br J Cancer; 2020 Feb; 122(3):434-444. PubMed ID: 31806880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
    Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA
    J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer.
    Chen G; Yang Z; Feng M; Wang Z
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT2 Receptor Mediated Activation of the Tyrosine Phosphatase PTP1B Blocks Caveolin-1 Enhanced Migration, Invasion and Metastasis of Cancer Cells.
    Martínez-Meza S; Díaz J; Sandoval-Bórquez A; Valenzuela-Valderrama M; Díaz-Valdivia N; Rojas-Celis V; Contreras P; Huilcaman R; Ocaranza MP; Chiong M; Leyton L; Lavandero S; Quest AFG
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31484460
    [No Abstract]   [Full Text] [Related]  

  • 15. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
    Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
    Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.
    Masuelli L; Budillon A; Marzocchella L; Mrozek MA; Vitolo D; Di Gennaro E; Losito S; Sale P; Longo F; Ionna F; Lista F; Muraro R; Modesti A; Bei R
    J Cell Physiol; 2012 Sep; 227(9):3344-53. PubMed ID: 22213373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
    Liu YP; Sun XH; Cao XL; Jiang WW; Wang XX; Zhang YF; Wang JL
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1759-1767. PubMed ID: 28485805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAK regulates E-cadherin expression via p-SrcY416/p-ERK1/2/p-Stat3Y705 and PPARγ/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
    Pei G; Lan Y; Chen D; Ji L; Hua ZC
    Oncotarget; 2017 Feb; 8(8):13898-13908. PubMed ID: 28108732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN14, a target gene of miR-4295, restricts the growth and invasion of osteosarcoma cells through inactivation of YAP1 signalling.
    Liang G; Duan C; He J; Ma W; Dai X
    Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1301-1310. PubMed ID: 32141101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.